Skip to main content
Molecure S.A. logo

Molecure S.A. — Investor Relations & Filings

Ticker · MOC ISIN · PLONCTH00011 LEI · 2594003L11V38ZCVKZ09 WAR Professional, scientific and technical activities
Filings indexed 194 across all filing types
Latest filing 2026-06-02 Regulatory Filings
Country PL Poland
Listing WAR MOC

About Molecure S.A.

https://molecure.com/

Molecure S.A. is a clinical-stage biotechnology company focused on discovering and developing first-in-class small molecule drugs for diseases with high unmet medical needs. The company utilizes its expertise in medicinal chemistry and biology to identify, validate, and modulate novel protein and mRNA targets. Its therapeutic pipeline is concentrated on oncological, inflammatory, and fibrotic diseases. Molecure operates a proprietary discovery platform for targeting mRNA with small molecules, enabling the development of innovative therapies for previously untreatable conditions.

Recent filings

Filing Released Lang Actions
sprawozdanie o wynagrodzeniach RN i Zarządu za 2025 r.
Regulatory Filings
2026-06-02 Polish
projekty uchwał na ZWZ
Regulatory Filings
2026-06-02 Polish
wzór pełnomocnictwa na ZWZ
Regulatory Filings
2026-06-02 Polish
sprawozdanie Rady Nadzorczej za 2025 r.
Regulatory Filings
2026-06-02 Polish
opinia biegłego o sprawozdaniu o wynagrodzeniach
Regulatory Filings
2026-06-02 Polish
Projekty uchwał Zwyczajnego Walnego Zgromadzenia - Content (PL)
Regulatory Filings
2026-06-02 Polish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.